GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Other Current Receivables

Indo-Bangla Pharmaceuticals (DHA:IBP) Other Current Receivables : BDT0.00 Mil (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Other Current Receivables?

Indo-Bangla Pharmaceuticals's Other Current Receivables for the quarter that ended in . 20 was BDT0.00 Mil.


Indo-Bangla Pharmaceuticals Other Current Receivables Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Other Current Receivables Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Other Current Receivables

Indo-Bangla Pharmaceuticals Semi-Annual Data
Other Current Receivables

Indo-Bangla Pharmaceuticals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Indo-Bangla Pharmaceuticals Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.